newsfilter
← Latest News
GlobeNewswire·

Prometheus Biosciences to Participate at November Healthcare Conferences

SAN DIEGO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (NASDAQ:RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and